t-cell |
GTBP |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
942.857142857143 |
cancer |
GTBP |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
942.857142857143 |
ceiling |
GTBP |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
942.857142857143 |
treatment |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
337.710437710438 |
respiratory |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
337.710437710438 |
covid |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
337.710437710438 |
antibody |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
337.710437710438 |
monoclonal antibodies |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
337.710437710438 |
education |
UMEWF |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
199.065420560748 |
treatment |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
168.595041322314 |
respiratory |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
168.595041322314 |
covid |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
168.595041322314 |
antibody |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
168.595041322314 |
monoclonal antibodies |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
168.595041322314 |
t-cell |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
136.826524570752 |
gene therapies |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
136.826524570752 |
genetic |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
136.826524570752 |
cancer |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
136.826524570752 |
ceiling |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
136.826524570752 |
treatment |
TPST |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
77.2020725388601 |
endocrine |
TPST |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
77.2020725388601 |
pathogens |
CYTO |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
59.5959595959596 |
treatment |
CYTO |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
59.5959595959596 |
hepatitis |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
47.794199355484 |
cancer |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
47.794199355484 |
ovarian cancer |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
47.794199355484 |
treatment |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
47.794199355484 |
vaccine |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
47.794199355484 |
msa |
SPRY |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
30.7692307692308 |
alzheimer’s |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
rap |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
platform |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
sclerosis |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
tempo |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
potential |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
phase 1 |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
pot |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
neurodegenerative |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
therapeutics |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
program |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
rapid |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
als |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
alzheimer |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
tiona |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
parkinson's |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
drug discovery |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
gen |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
alzheimer's |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
cov |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
cel |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
disease |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
ytx-7739 |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
system |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
candidate |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
drug |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
arm |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
pharma |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
parkinson |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
alzheimer's disease |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
com |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
biopharma |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
dementia |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
treatment |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
26.4150943396226 |
msa |
KPRX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
20.8333333333333 |
alzheimer’s |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
rap |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
platform |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
sclerosis |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
tempo |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
potential |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
phase 1 |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
pot |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
neurodegenerative |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
therapeutics |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
program |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
rapid |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
als |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
alzheimer |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
tiona |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
parkinson's |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
drug discovery |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
gen |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
alzheimer's |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
cov |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
cel |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
disease |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
ytx-7739 |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
system |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
candidate |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
drug |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
arm |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
pharma |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
parkinson |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
alzheimer's disease |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
com |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
biopharma |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
dementia |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
treatment |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
20.5686521504409 |
msa |
KPRX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
18.3673469387755 |
als |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
16.1290322580645 |
t-cell |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
16.1290322580645 |
antibody |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
16.1290322580645 |
treatment |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
16.1290322580645 |
ceiling |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
16.1290322580645 |
hepatitis |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
15.6521739130435 |
cancer |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
15.6521739130435 |
ovarian cancer |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
15.6521739130435 |
treatment |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
15.6521739130435 |
vaccine |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
15.6521739130435 |
hepatitis |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
13.6752136752137 |
cancer |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
13.6752136752137 |
ovarian cancer |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
13.6752136752137 |
treatment |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
13.6752136752137 |
vaccine |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
13.6752136752137 |
pathogens |
CYTO |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
12.8571428571429 |
treatment |
CYTO |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
12.8571428571429 |
ontak |
NOTV |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
12.2685185185185 |
education |
NOTV |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
12.2685185185185 |
injection |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
pancreatic |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
trial |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
trials |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
gastrointestinal |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
test |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
clinical trials |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
fibrosis |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
diarrhea |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
biopharma |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
phase 2 |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
treatment |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
disease |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
covid |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1y |
12.2302158273381 |
treatment |
MNKKQ |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
10.4972375690608 |
acquisitions |
MNKKQ |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
10.4972375690608 |
diagnostics |
MNKKQ |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
10.4972375690608 |
treatment |
TPST |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
10.3225806451613 |
endocrine |
TPST |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
10.3225806451613 |
t-cell |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
10.091743119266 |
gene therapies |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
10.091743119266 |
genetic |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
10.091743119266 |
cancer |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
10.091743119266 |
ceiling |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
10.091743119266 |
injection |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
pancreatic |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
trial |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
trials |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
gastrointestinal |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
test |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
clinical trials |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
fibrosis |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
diarrhea |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
biopharma |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
phase 2 |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
treatment |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
disease |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
covid |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
9.85915492957747 |
ontak |
NOTV |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
9.7285067873303 |
education |
NOTV |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
9.7285067873303 |
treatment |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
8.24313072439634 |
respiratory |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
8.24313072439634 |
covid |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
8.24313072439634 |
antibody |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
8.24313072439634 |
monoclonal antibodies |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
8.24313072439634 |
treatment |
DRUG |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
7.82608695652173 |
injection |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
pancreatic |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
trial |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
trials |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
gastrointestinal |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
test |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
clinical trials |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
fibrosis |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
diarrhea |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
biopharma |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
phase 2 |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
treatment |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
disease |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
covid |
FWBI |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
7.21649484536083 |
t-cell |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
7.14285714285714 |
gene therapies |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
7.14285714285714 |
genetic |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
7.14285714285714 |
cancer |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
7.14285714285714 |
ceiling |
TCRT |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
7.14285714285714 |
ceiling |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.93069306930694 |
als |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.93069306930694 |
t-cell |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.93069306930694 |
antibody |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.93069306930694 |
treatment |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.93069306930694 |
treatment |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.47010647010646 |
respiratory |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.47010647010646 |
covid |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.47010647010646 |
antibody |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.47010647010646 |
monoclonal antibodies |
AVTX |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.47010647010646 |
alzheimer’s |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
rap |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
platform |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
sclerosis |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
tempo |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
potential |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
phase 1 |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
pot |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
neurodegenerative |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
therapeutics |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
program |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
rapid |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
als |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
alzheimer |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
tiona |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
parkinson's |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
drug discovery |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
gen |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
alzheimer's |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
cov |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
cel |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
disease |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
ytx-7739 |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
system |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
candidate |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
drug |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
arm |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
pharma |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
parkinson |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
alzheimer's disease |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
com |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
biopharma |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
dementia |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
treatment |
KA |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
6.34920634920636 |
treatment |
TPST |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
5.55555555555554 |
endocrine |
TPST |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
5.55555555555554 |
pathogens |
CYTO |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
5.33333333333334 |
treatment |
CYTO |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
5.33333333333334 |
hepatitis |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
4.72440944881892 |
cancer |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
4.72440944881892 |
ovarian cancer |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
4.72440944881892 |
treatment |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
4.72440944881892 |
vaccine |
IMNN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
4.72440944881892 |
als |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
4.34782608695654 |
t-cell |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
4.34782608695654 |
antibody |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
4.34782608695654 |
treatment |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
4.34782608695654 |
ceiling |
ELDN |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
4.34782608695654 |
msa |
SPRY |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
3d |
3.53227771010962 |
t-cell |
RGBP |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
2.94117647058823 |
profitable |
KMPH |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
0.683760683760681 |
profitable |
KMPH |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
0.683760683760681 |
treatment |
KMPH |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
0.683760683760681 |
treatment |
KMPH |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
0.683760683760681 |
urea |
KMPH |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
1m |
0.683760683760681 |
urea |
KMPH |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
0.683760683760681 |
msa |
SPRY |
Manufacturing |
Pharmaceutical Preparation Manufacturing |
7d |
0.354191263282161 |